首都儿研所发文称院内制剂遭仿冒虚假宣传！已启动专项维权

Core Viewpoint - The Capital Pediatric Research Institute and the Capital Medical University Affiliated Capital Children's Medical Center have identified unauthorized products in the market that closely resemble their approved formulations, leading to illegal promotion and sales that mislead parents in product selection [1][2]. Group 1: Unauthorized Products - Unauthorized products have been found in the market that use similar or highly similar names, packaging, and labeling to the institute's formulations, including cosmetics, medical devices, and disinfectants [1]. - These infringing products lack legal approval, have unclear formulations, and pose significant health risks to children due to potential differences in ingredients, processes, and quality control [1][2]. Group 2: Legal Actions - The institute has engaged a professional legal team to initiate a special rights protection action against the unauthorized use of their product names and formulations [3].